reNEW is an international consortium of three leading research institutions in Denmark, Australia and the Netherlands, led by renowned Professor and CEO Melissa Little. We strive to advance a new generation of effective and safe stem cell-based therapies, built on a global collaborative network of excellence in targeted biomedical research.